Idan wani a cikin iyalinka, wataƙila mahaifiyarka, mahaifinka, ko ƙaunataccenka, yana fama da cutar Alzheimer, mun san yadda yake da wahala. Ba za a iya kwatanta baƙin ciki da rashin taimako da kake ji ba yayin da tunaninka ke ɓacewa a hankali kuma ba ka sake gane ƙaunatattunka ba. Duk da haka, yanzu akwai ɗan ƙaramin bege a cikin wannan duhu. Kwanan nan, Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da wani sabon magani don cutar Alzheimer.
Menene wannan sabon maganin?
Sunan wannan sabon maganin da aka amince da shi shine donanemab . Ana samunsa a kasuwa da sunan Kisunla. Wannan magani ba magani bane da ake bai wa duk masu cutar Alzheimer. Ana yin sa ne musamman ga mutanen da ke farkon cutar. Wato, waɗanda suka fara nuna wasu matsaloli a ƙwaƙwalwar ajiya da tunani. A fannin likitanci, ya dace da marasa lafiya da ke da ɗan matsalar fahimta ko kuma wani nau'in cutar hauka .
A taƙaice dai, cutar Alzheimer tana faruwa ne sakamakon tarin wani nau'in furotin da ba a so da ake kira amyloid a cikin kwakwalwa. Kamar toshewar bututun ruwa ne da ƙura ke haifarwa. Kafin a yi wannan sabon magani, ana buƙatar yin gwajin jini don tabbatar da ko majiyyacin yana da waɗannan tarin amyloid a cikin kwakwalwarsa.
Menene babban abin da ya fi muhimmanci game da wannan maganin?
Babban kuma mafi mahimmanci game da wannan maganin shine ba magani ne na tsawon rai ba. Ka yi tunanin, dole ne a sha da yawa daga cikin magungunan da ake amfani da su a yanzu kamar wannan akai-akai. Amma bambancin juyin juya hali da donanemab shine cewa za a iya dakatar da maganin bayan an cire waɗannan amyloid da ba a so a cikin kwakwalwa.
Wannan babban ci gaba ne. Wannan amincewa tana ba wa marasa lafiya ƙarin zaɓuɓɓuka, da kuma damar yin ɗan lokaci tare da ƙaunatattunsu, tare da ƙarin tunawa.
Masana sun yi imanin cewa ta hanyar dakatar da magani ta wannan hanyar, adadin lokutan da majiyyaci ke buƙatar zuwa asibiti, rashin jin daɗin da yake ji, da kuma kuɗin magani za a iya rage shi sosai.
Shin babu wata haɗari ko illa?
Ba shakka, kamar dukkan magunguna, akwai wasu haɗari. Ba za mu iya yin watsi da su ba. Babban haɗarin da ke tattare da wannan maganin shine wata cuta da ake kira ARIA (Amyloid-Related Imaging Abnormalities) .
A taƙaice dai, wannan na iya haifar da ƙaramin kumburi a cikin kwakwalwa (ƙumburin kwakwalwa) ko kuma ƙaramin zubar jini (zubar da jini a kwakwalwa) . Waɗannan kalmomin na iya yin kama da abin tsoro, amma masana sun ce ana iya magance wannan haɗarin. Shi ya sa yake da mahimmanci a san da shi yayin magani.Ana sa ido sosai kan kwakwalwa ta hanyar yin gwajin MRI akai-akai. Idan aka lura da wasu canje-canje, likita zai ɗauki matakan da suka dace.
Saboda haka, idan kuna la'akari da wannan maganin, yana da matuƙar muhimmanci ku yi magana a fili da likitanku game da fa'idodi da rashin amfanin wannan maganin, wato fa'idodi da haɗari, ba tare da ɓoye komai ba.
| Amfanin Donanemab | Rashin amfani da haɗarin Donanemab |
|---|---|
| Yana cire tarin amyloid a cikin kwakwalwa wanda ke haifar da cutar Alzheimer. | Haɗarin ARIA (kumburin kwakwalwa ko zubar jini). |
| Yana rage saurin lalacewar ƙwaƙwalwa da ikon tunani. | Yana da mahimmanci a riƙa lura da kwakwalwa ta hanyar amfani da na'urar duban MRI akai-akai. |
| Yiwuwar dakatar da magani da zarar amyloid ya warke. | Illolin da aka saba gani kamar ciwon kai da tashin zuciya na iya faruwa. |
| Rage lokacin magani da kuɗin magani a cikin dogon lokaci. | Wannan ba magani bane da ke warkar da cutar gaba ɗaya, kawai yana sarrafa tabarbar da cutar ke yi ne. |
Shin wannan maganin yana samuwa a ƙasarmu?
A wannan lokacin, ana amincewa da donanemab ne kawai a Amurka. Don haka zai ɗauki ɗan lokaci kafin wannan magani ya kasance a asibitocin Sri Lanka. Haka kuma, yana da ɗan tsada. Duk da haka, idan wannan magani ya zo Sri Lanka a nan gaba, yana yiwuwa marasa lafiya su sami ɗan sauƙi tare da sa hannun gwamnati da inshora.
Duk da haka, sabbin abubuwan da aka gano kamar waɗannan sun nuna cewa kimiyya tana samun ci gaba a hankali a yaƙi da cutar Alzheimer. Wannan da kanta yana ba mu babban bege.
Saƙon Ɗauka Gida
- Donanemab sabuwar magani ce da aka amince da ita don magance cutar Alzheimer's a farkon matakanta .
- Wannan yana cire sunadaran amyloid masu cutarwa waɗanda ke taruwa a cikin kwakwalwa kuma yana rage ci gaban cutar.
- Yana da muhimmanci a fahimci cewa wannan ba magani bane gaba ɗaya.
- Babban fa'idar wannan maganin shine cewa ana iya dakatar da shi da zarar an cire amyloid daga kwakwalwa.
- Saboda yuwuwar kamuwa da cututtuka masu haɗari kamar ARIA, kulawa ta musamman daga likita da kuma na'urar duban MRI suna da mahimmanci a duk tsawon lokacin magani.
- Kafin ka yanke shawara game da lafiyarka ko ta wanda kake ƙauna, koyaushe ka tattauna duk zaɓuɓɓuka, fa'idodi, da haɗari tare da likitanka.
💬 Comments (0)
Har yanzu ba a buga sharhi ba. Ƙara bayanin ku anan a karon farko.
Ƙara sharhin ku